Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 47 out of 100. End-of-life care

Topic: Risk, prevention and care in population studies

BackgroundLet's Talk Tech (LTT) is a self-administered web intervention for people with memory loss and their care partners that supports decision-making about digital health technologies. In past work, dyads wanted to share LTT preference reports with their larger care networks.ObjectiveThis study aims to understand with whom care dyads want to share their technology preference reports and why, and if and how clinicians want to receive them.MethodsTogether, fifteen dyads of people living with mild cognitive impairment (MCI) or early-stage dementia (n = 15) and a care partner (n = 15) completed LTT and two survey questions. Care partners completed independent follow-up interviews, and 32 clinicians at four Alzheimer's Disease Research Center-affiliated clinics viewed an LTT report and completed a 10-question survey. We used descriptive statistics for survey responses and thematic analysis for interviews.ResultsTwo-thirds of care partners (n = 10) wanted to share the report with family members. Half (n = 8) wanted to share it with clinicians to keep them informed about the dyad's planning and facilitate conversations about technology options. 30 of 32 clinicians reported they would want their patients' technology preferences reports, with 25 wanting to access it via the electronic health record (EHR).ConclusionsFindings demonstrate potential value to both family dyads and providers of sharing technology preferences beyond the care dyad. Clinicians were highly receptive to accessing technology preference reports in EHRs and to having discussions about technology be a part of advance care planning. Future research should test integration in the EHR and the potential of sharing technology preferences to support person-centered technology choices.

Key findings

Why it matters

In this study, most care partners wanted to share technology preference reports with family and clinicians, and 30 of 32 clinicians said they would want such reports. It concerns sharing preferences about digital health technologies, not treating or preventing Alzheimer's disease.

Study details

How this study scored 47/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 1 of 6; Still being cited 1 of 4; Senior author's track record 4 of 4; Institution's track record 3 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 47 of 100.47 of 100 points earned53 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of Alzheimer s Disease)
Journal's citation record 2 / 4 Journal of Alzheimer s Disease: journal h-index 218 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 1 / 4 15 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 7.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Jeffrey Alan Kaye: h-index 122 (OpenAlex, whole career)
Institution's track record 3 / 3 University of Washington: institution h-index 3,540 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40313054)
Free to read 2 / 2 Free to read
Total 47 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Berridge, C. W., Turner, N. R., Lober, W. B., Demiris, G., & JEFFREY A., K. A. Y. E. (2025). Sharing patient technology preferences with care networks: Stakeholders’ views of the “Let’s Talk Tech” decision aid for dementia care. Journal of Alzheimer s Disease. https://doi.org/10.1177/13872877251332659

Vancouver

Berridge CW, Turner NR, Lober WB, Demiris G, JEFFREY A. KAYE. Sharing patient technology preferences with care networks: Stakeholders’ views of the “Let’s Talk Tech” decision aid for dementia care. Journal of Alzheimer s Disease. 2025. doi:10.1177/13872877251332659. PMID: 40313054.

BibTeX

@article{berridge2025-40313054,
  author  = {Berridge, Clara W. and Turner, Natalie R. and Lober, William B. and Demiris, George and JEFFREY A., K. A. Y. E.},
  title   = {{Sharing patient technology preferences with care networks: Stakeholders’ views of the “Let’s Talk Tech” decision aid for dementia care}},
  journal = {Journal of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1177/13872877251332659},
  pmid    = {40313054},
  url     = {https://doi.org/10.1177/13872877251332659}
}

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in End-of-life care

Similar studies

More on End-of-life care

See all studies in End-of-life care →